The nucleus accumbens (NAc), a major component of the mesolimbic system, is involved in the 69 mediation of reinforcing and addictive properties of many dependence-producing drugs. 70
within the NAc suggests the potential for interplay between the signaling cascades activated by 123 these two receptors, which belong to the 7-trans-membrane G protein-coupled receptors 124 superfamily (Pertwee 1997; Barnes and Sharp 1999). Interestingly, 5-HT 2 receptors activation 125 strongly suppresses excitatory postsynaptic currents (EPSCs) in the inferior olive, by releasing 126 eCBs that suppress glutamate release through presynaptic CB1 receptors activation (Best and 127 Regehr 2008) . 128
In the present study, performed in a rat slice preparation containing the NAc, we found that 129 prolonged (20 min) low-frequncy (4 Hz) stimulation (LFS-4Hz) of glutamatergic afferences induces 130 a novel form of eCB-LTD in the NAc core, which requires 5-HT 2 and CB1 receptors activation and 6
The experiments were carried out in parasagittal brain slices including the NAc. The slices were 142 prepared as previously described by Li and Kauer (2004) . Briefly, rats were deeply anaesthetized 143 using halothane (Sigma-Aldrich, Milan, Italy) and quickly decapitated. Their brains were rapidly 144 removed and immerged in ice-cold artificial cerebrospinal fluid (aCSF), containing (in mM): NaCl, 145 119; KCl, 2,5; NaH 2 PO 4 , 1; NaHCO 3 , 26; MgSO 4 , 1,3; CaCl 2 2,5; glucose, 10; kynurenic acid, 1; 146 saturated with 95% O 2 , 5% CO 2 (295 mOsm/l, pH 7.4). Parasagittal midbrain slices (400 μm thick) 147 were obtained from the blocked brain using a vibrating microtome, and then transferred to a tissue 148 bath containing aCSF without kinurenic acid at room temperature until use. 149
Electrophysiological Recordings 150
After recovering for at least 60 min, a single slice was transferred to a submersion recording 151 chamber and perfused at the rate of 2 ml/min with aCSF without kinurenic acid maintained at room 152 temperature, saturated with 95% O 2 and 5%.CO 2 , and added with 50 μM picrotoxin (Sigma-Aldrich, 153
Milan, Italy) to block GABA A receptors. Recordings started 30 min after the slice was placed into 154 the chamber. Field excitatory postsynaptic potentials (fEPSPs) evoked by glutamatergic afferent 155 pathway stimulation were recorded in the NAc core with an extracellular microelectrode (glass 156 micropipette filled with aCSF, 2-8 M ) connected to a dc amplifier by an Ag/AgCl electrode.
Drug Application

167
Drugs were applied by switching from the control solution to one that differed only for the presence 168 of the added drug. The following pharmacological compounds were applied in this study: the 169 GABA A receptors blocker picrotoxin (50 μM), the L-type VGCC blocker nifedipine hydrochloride 170 (10 μM) and the ionotropic glutamate receptors antagonist kynurenic acid (1mM) (these compounds 171 were purchased from Sigma-Aldrich, Milan, Italy); the N-methyl-D-aspartate receptors (NMDAR) 172 antagonist D-amino-5-phosphonovaleric acid (D-AP5), the CB1 receptors antagonist N-(piperidin-173 1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1 H-pyrazole-3-carboxamide (AM251; 2 174 μM) and 4-[[6-methoxy-2-(4-methoxyphenyl)-3-benzofuranyl]carbonyl]benzonitrile (LY320135; 175 10 μM), the mGluR 1 antagonist (S)-(+)-α-amino-4-carboxy-2-methyl-benzeneacetic acid 176 (LY367385), the mGluR 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP), the mGluR 2/3 177 antagonist 2-amino-2-(2carboxycyclopropan-1-yl)-3-(dibenzopyran-4-yl) propanoic acid 178 (LY341495), 5-hydroxytryptamine hydrobromide (5-HT; 5 μM), the 5-HT 2 receptor antagonist 179 ketanserin tartrate (10 μM), the 5-HT 1 receptor antagonist pindolol (10 μM), the TRPV1 antagonist 180 capsazepine (10 μM), the D1 receptor antagonist SCH23390 (25 μM), the D2 receptor antagonist 181 sulpiride (25 μM), the diacylglycerol lipase α (DGL) inhibitor tetrahydrolipstatin (THL; 10 μM) and 182 the fatty acid amide hydrolase (FAAH) inhibitor JNJ-1661010 (1 μM), the selective 5-HT reuptake 183 inhibitor (SSRI) citalopram hydrobromide (4 μM), the 5-HT 2 selective agonist alpha-methyl-5-184 hydroxytryptamine maleate (alpha-methyl 5-HT; 20 μM), the selective monoacylglycerol lipase 185 (MAGL) inhibitor 4-[bis(1,3-benzodioxol-5-yl)hydroxyl-methyl]-1-piperidinecarboxylic acid 4-186 nitrophenyl ester (JZL 184; 50 μM); (these compounds were purchased from Tocris Cookson, 187 Bristol, UK). Drugs were made up in dimethyl sulfoxyde (DMSO) or bidistilled water stock 188 solutions and diluted 1000 times into the superfusing aCSF, yielding to their final concentrations. In 189 a subset of control experiments (4 slices), 0.1% DMSO was also added to the slice-perfusing aCSF: 190 LFS-4Hz elicited normal LTD in each of these slices, therefore data obtained were pooled with exception of kynureate, 5-HT and alpha-methyl 5-HT, none of the drugs used affected basal 193 synaptic transmission. 194
Data Analysis
195
Sweeps of 1000 ms comprising the artefact, the non-synaptic components and the fEPSP were 196 digitally acquired using the software Axoscope 9.0 (Axon instruments, PA, USA) and analysed 197 offline using the software Clampfit (Axon instruments, PA, USA); the peak amplitude values (mV) 198 were exported in an Excel file. Each amplitude value was normalized to the baseline (calculated as 199 the mean of the fEPSP amplitudes recorded in the last 10 min before application of LFS-4Hz). All 
Results
212
We recorded fEPSPs evoked in the NAc core by the stimulation of glutamatergic afferences. We 213 found that LFS-4Hz (20 min stimulation at 4 Hz) induces a robust LTD (n=8; Fig.1 Table 1 ). To evaluate the involvement of postynaptic ionotropic glutamate receptors, the 222 slices were perfused with the non-subtype-selective ionotropic glutamate receptors antagonist 223 kynureate (1 mM) 20 min before and during LFS-4Hz stimulation. As expected, kynureate 224 completely blocked fEPSP, but did not prevent LTD induction (n=8; Fig. 1 whether also LFS-4Hz would induce this form of LTD in our experimental conditions, by applying 231 the mGlu 2/3 antagonist LY341495 (0.2 μM) 20 min before and during LFS-4Hz stimulation. We 232 found that antagonism at the mGluR 2/3 had no effect on LTD induction (n=6; Fig. 1 , C and D; 233 Table 1) . 234
, A and D; 214
In addition to NMDA-and mGlu2/3-dependent LTD, NAc synapses have been shown to display 235 eCB-LTD, which depends on the production of eCBs acting at CB1 receptors ( Table 1 ). The two main eCBs produced upon neuronal stimulation in the brain 240 are AEA and 2-AG (Piomelli, 2003). We first attempted to evaluate the involvement of 2-AG in 241 LFS-4Hz, slices were treated with THL (10 μM), an inhibitor of the 2-AG-producing enzyme DGL. 242
As shown in Fig. 2 , A and C, pre-incubation of the slices (>2 hours) with THL, completely prevented LTD induction (n=9; Table 1 ). We next examined whether also AEA was involved in 244 LFS-4Hz-induced LTD. To test this possibility, we used a weaker stimulation protocol (10 min 245 instead of 20 min at 4 Hz, LFS-weak), subthreshold to LTD induction in control conditions (n=5; 246 Fig. 2 , B and C; Table 2 ). Then, endogenous AEA production was increased by blocking the 247 activity of the FAAH -the enzyme responsible for AEA degradation -by adding JNJ-1661010. As 248 shown in Fig. 2 Table 1 ). Moreover, we performed a series 258 of experiments using the 10 Hz/5 min stimulation protocol and we found that -in our experimental 259 conditions -this protocol does not induce LTD (mean fEPSP was 106.52 ± 4.67%, 55-60 min after 260 10 Hz/5 min LFS; n=6, data not shown). 261
Since it has been shown that eCB-LTD in the NAc requires activation of the mGluR 5 (Robbe et al. 262
2002b), we also tested its involvement in the LTD obtained in our experimental conditions: 263 application of the mGluR 5 antagonist MPEP (10 μM) during LFS-4Hz did not affect LTD 264 induction (n=4; Fig. 1 , C and D; Table 1 ). We further investigated the involvement of group I 265 mGluRs (which comprises both mGluR 1 and mGluR 5) by applying the mGluR 1 antagonist Table 3 ). To test if the effect of 5-HT-LTD was 289 mediated by 5-HT 2 receptors, slices were perfused with the specific 5-HT 2 receptor agonist alpha-290 methyl 5-HT (20 μM): as shown in Fig. 3, B and E, the agonist mimicked the effect of 5-HT (n=6) 291 to induce LTD. A comparison of the amplitude of the LTD obtained in the presence of 5-HT vs. 292 alpha-methyl 5-HT revealed that the magnitude of LTD was significantly increased by the latter 293 treatment. To further test the involvement of 5-HT 2 receptors in 5-HT-LTD, slice were perfused depicted in Fig. 3 , C and E, ketanserin completely prevented the effect of 5-HT on fEPSP amplitude 296 (n=6 ; Table 3 ). We then tested whether the effects of 5-HT on synaptic transmission was mediated 297 by the CB1 receptors: co-application of 5-HT and the CB1 receptors antagonist AM251 (2 μM) 298 completely prevented 5-HT-LTD (n=4; Fig. 3 , C and E; Table 3 ) (n= 4). We next examined the 299 involvement of the L-type VGCC in 5-HT-LTD by applying 5-HT (5 μM) along with the specific 300 antagonist nifedipine (10 μM). As depicted in Fig. 3 , C and E, nifedipine completely prevented 5-301
HT-LTD (n=4; Table 3 ). To test whether endogenous 5-HT in the acute slice preparation would 302 facilitate the induction of LTD, the subthreshold stimulation protocol LFS-weak was applied in the 303 presence of the SSRI citalopram (4 μM). fibres in the NAc core increases the release of 5-HT acting at 5-HT 2 receptors, causing an increase 766 in Ca 2+ influx through L-type VGCC and leading to 2-AG production and release; the eCB travels 767 retrogradely and binds to presynaptic CB1 receptors, causing a long-lasting decrease of glutamate 768 release resulting in LTD. Abbreviations: GLU= glutamate; AMPA=α-amino-3-hydroxy-5-methyl- 97.84 ± 3.09 P < 0.05 P < 0.05 This table summarizes the effects of bath application of 5-HT on synaptic transmission in nucleus accumbens slices in control conditions or after pre-application of the drugs. Means % of field EPSP amplitude ± SEM have been calculated from the values recorded between 55 and 60 min after 5-HT application.
